1
|
Leong WL. From RECIST to PERCIST: navigating the landscape of tumor response assessment. Eur Radiol 2023:10.1007/s00330-023-10435-3. [PMID: 37955672 DOI: 10.1007/s00330-023-10435-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 09/16/2023] [Accepted: 09/20/2023] [Indexed: 11/14/2023]
Affiliation(s)
- Wai Ling Leong
- Department of Biomedical Imaging, Faculty of Medicine, University Malaya Research Imaging Centre, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
| |
Collapse
|
2
|
Homayoun H, Chan WY, Kuzan TY, Leong WL, Altintoprak KM, Mohammadi A, Vijayananthan A, Rahmat K, Leong SS, Mirza-Aghazadeh-Attari M, Ejtehadifar S, Faeghi F, Acharya UR, Ardakani AA. Applications of machine-learning algorithms for prediction of benign and malignant breast lesions using ultrasound radiomics signatures: A multi-center study. Biocybern Biomed Eng 2022. [DOI: 10.1016/j.bbe.2022.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
3
|
Mushonga M, Kwan JYY, Purdie TG, Chaulk G, DeRocchis J, Munhoz RP, Leong WL, Hodaie M, Liu FF. Deep Brain Stimulators and Radiation Therapy in Cancer Patients. Clin Oncol (R Coll Radiol) 2022; 34:e136-e138. [PMID: 34996683 DOI: 10.1016/j.clon.2021.12.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2021] [Accepted: 12/21/2021] [Indexed: 11/17/2022]
Affiliation(s)
- M Mushonga
- Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
| | - J Y Y Kwan
- Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
| | - T G Purdie
- Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
| | - G Chaulk
- Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
| | - J DeRocchis
- Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
| | - R P Munhoz
- Department of Medicine, Division of Neurology, University Health Network, Toronto, Ontario, Canada
| | - W L Leong
- Department of Surgery, Division of General Surgery, University Health Network, Toronto, Ontario, Canada
| | - M Hodaie
- Department of Surgery, Division of Neurosurgery, University Health Network, Toronto, Ontario, Canada
| | - F-F Liu
- Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
4
|
Leong WL, Lai LL, Nik Mustapha NR, Vijayananthan A, Rahmat K, Mahadeva S, Chan WK. Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2020; 35:135-141. [PMID: 31310032 DOI: 10.1111/jgh.14782] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Revised: 05/27/2019] [Accepted: 07/10/2019] [Indexed: 12/13/2022]
Abstract
BACKGROUND AND AIM Transient elastography (TE) and point shear wave elastography (pSWE) are noninvasive methods to diagnose fibrosis stage in patients with chronic liver disease. The aim of this study is to compare the accuracy of the two methods to diagnose fibrosis stage in non-alcoholic fatty liver disease (NAFLD) and to study the intra-observer and inter-observer variability when the examinations were performed by healthcare personnel of different backgrounds. METHODS Consecutive NAFLD patients who underwent liver biopsy were enrolled in this study and had two sets each of pSWE and TE examinations by a nurse and a doctor on the same day of liver biopsy procedure. The medians of the four sets of pSWE and TE were used for evaluation of diagnostic accuracy using area under receiver operating characteristic curve (AUROC). Intra-observer and inter-observer variability was analyzed using intraclass correlation coefficients. RESULTS Data for 100 NAFLD patients (mean age 57.1 ± 10.2 years; male 46.0%) were analyzed. The AUROC of TE for diagnosis of fibrosis stage ≥ F1, ≥ F2, ≥ F3, and F4 was 0.89, 0.83, 0.83, and 0.89, respectively. The corresponding AUROC of pSWE was 0.80, 0.72, 0.69, and 0.79, respectively. TE was significantly better than pSWE for the diagnosis of fibrosis stages ≥ F2 and ≥ F3. The intra-observer and inter-observer variability of TE and pSWE measurements by the nurse and doctor was excellent with intraclass correlation coefficient > 0.96. CONCLUSION Transient elastography was significantly better than pSWE for the diagnosis of fibrosis stage ≥ F2 and ≥ F3. Both TE and pSWE had excellent intra-observer and inter-observer variability when performed by healthcare personnel of different backgrounds.
Collapse
Affiliation(s)
- Wai Ling Leong
- Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - Lee Lee Lai
- Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | | | - Anushya Vijayananthan
- Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - Kartini Rahmat
- Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - Sanjiv Mahadeva
- Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - Wah Kheong Chan
- Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| |
Collapse
|
5
|
Leong WL, Battiston K, Cheung F, Fulton C, Lin A, Levin W, Done S, Santerre P. Abstract P3-13-11: The outcomes of ReFilx soft tissue filler as an immediate reconstruction technique for lumpectomy followed by radiotherapy. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p3-13-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Lumpectomy for breast cancer can often result in poor cosmetic outcomes which can lead to long-lasting impairment of quality of life. ReFilx is a synthetic porous degradable polyurethane scaffold that has mechanical properties comparable to that of native healthy breast tissue. It has been shown in two previous porcine studies to preserve breast shape and volume over 9 months when inserted into the cavities immediately after lumpectomy. We observed minimal foreign body reaction with good integration of the host tissue while the material degraded over time. In this study, we examined the healing process of lumpectomy treated with radiation. Radiotherapy is currently a standard adjuvant therapy after lumpectomy for breast cancers; and radiation is known to affect the healing process in general. Objective: To evaluate ReFilx, as soft tissue fillers for lumpectomy cavities in combination with standard radiotherapy. Hypothesis: ReFilx will preserve breast shape and volume by supporting tissue infiltration with minimal inflammation in the presence of clinically relevant radiotherapy. Methods: 3 female Yucatan minipigs received lumpectomies carried out using electrocautery to remove normal breast tissue of approximately 2 cm diameter, after which the cavities were filled with (case) or without ReFilx (sham control) (n=3 for each condition, each pig has 12-13 breasts). 6 weeks post-implantation, 2 of the pigs received radiation directed at the right half of their bodies (6 breasts per pig) for a total dose of 42.4 Gy delivered over 15 fractions using a clinical linear accelerator. The delivered doses to target sites and the adjacent tissue were confirmed with optically stimulated luminescent dosimeters (OSLDs). A third pig was maintained as a non-irradiated control. Ultrasound examinations were performed every 3 weeks post-implantation. At week 24 and 36, samples consisted of n=3 for irradiated and non-irradiated ReFilx and sham sites for the half-irradiated pigs, and n=3 for non-irradiated ReFilx and sham sites for the non-irradiated control pig were excised by mastecomy, the tissue samples were fixed in 10% buffered formalin for subsequent histological (H&E, Masson's Trichrome) studies. Potential side effects were monitored by vital signs, pain control, wound checks, ultrasound and blood tests. Necropsies were performed at the conclusion of the study. Results: Ultrasound examination indicated no difference between ReFilx's ability to maintain breast shape and volume with or without the presence of radiation treatment, in contrast to the collapse of the sham sites by 24 weeks. Similarly, the histology of irradiated and non-irradiated ReFilx samples showed similar levels of tissue infiltration, inflammatory changes and degradation of ReFilx. There was no significant side effects observed. Conclusions: ReFilx's ability to act as a soft tissue filler for breast volume restoration post-lumpectomy does not appear to be significantly impacted by the presence of clinically relevant radiation treatment. Longer-term follow-up is currently in progress for this study. Acknowledgements: Connaught Innovation Award (University of Toronto) and Joule Innovation Fund (Canadian Medical Association).
Citation Format: Leong WL, Battiston K, Cheung F, Fulton C, Lin A, Levin W, Done S, Santerre P. The outcomes of ReFilx soft tissue filler as an immediate reconstruction technique for lumpectomy followed by radiotherapy [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-13-11.
Collapse
Affiliation(s)
- WL Leong
- University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
| | - K Battiston
- University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
| | - F Cheung
- University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
| | - C Fulton
- University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
| | - A Lin
- University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
| | - W Levin
- University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
| | - S Done
- University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
| | - P Santerre
- University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
6
|
Seet E, Leong WL, Yeo ASN, Fook-Chong S. Effectiveness of 3-in-1 Continuous Femoral Block of Differing Concentrations Compared to Patient Controlled Intravenous Morphine for Post Total Knee Arthroplasty Analgesia and Knee Rehabilitation. Anaesth Intensive Care 2019; 34:25-30. [PMID: 16494145 DOI: 10.1177/0310057x0603400110] [Citation(s) in RCA: 56] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
We assessed the effectiveness of the 3-in-l continuous femoral block as a form of postoperative pain relief for unilateral total knee arthroplasty (TKA). Sixty patients undergoing elective unilateral TKA under subarachnoid block were randomized into three groups. Postoperative analgesia was provided with a continuous 3-in-l femoral nerve catheter with 0.15% ropivacaine in group A, a continuous 3-in-l femoral nerve catheter with 0.2% ropivacaine in group B, or patient controlled intravenous morphine in group C (control group). Groups A and B received patient controlled intravenous morphine pumps for rescue analgesia. Patients in each group were followed for 72 hours postoperatively. Five patients were excluded after randomization. In the remaining 55 patients there was no statistical difference in pain score between the groups. Total morphine use was highest in group C (P< 0.05). No appreciable difference could be found with sensorimotor blockade, morphine usage and satisfaction scores when comparing groups A and B. Femoral catheter dislodgement rate was 7.9%. There was no statistical difference between the groups when comparing the day of first ambulation and the time to discharge from the hospital. Satisfaction scores were higher in group A (P = 0.028) and group B (P = 0.002) compared to group C. We conclude that a continuous 3-in-l femoral nerve block with ropivacaine 0.15% or 0.2% for elective unilateral TKA has an opioid-sparing effect.
Collapse
MESH Headings
- Age Factors
- Aged
- Amides/administration & dosage
- Analgesia/adverse effects
- Analgesia/methods
- Analgesia, Patient-Controlled/methods
- Analgesics, Opioid/administration & dosage
- Analysis of Variance
- Arthroplasty, Replacement, Knee/adverse effects
- Arthroplasty, Replacement, Knee/methods
- Arthroplasty, Replacement, Knee/rehabilitation
- Dose-Response Relationship, Drug
- Female
- Femoral Nerve
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Morphine/administration & dosage
- Nerve Block/methods
- Pain Measurement
- Pain, Postoperative/diagnosis
- Pain, Postoperative/drug therapy
- Patient Satisfaction
- Probability
- Prospective Studies
- Risk Assessment
- Ropivacaine
- Severity of Illness Index
- Sex Factors
- Statistics, Nonparametric
- Treatment Outcome
Collapse
Affiliation(s)
- E Seet
- Singapore Health Services Pt Ltd, Singapore General Hospital, National Cancer Centre and Dover Park Hospice, Singapore
| | | | | | | |
Collapse
|
7
|
Acharya UR, Raghavendra U, Koh JEW, Meiburger KM, Ciaccio EJ, Hagiwara Y, Molinari F, Leong WL, Vijayananthan A, Yaakup NA, Fabell MKBM, Yeong CH. Automated detection and classification of liver fibrosis stages using contourlet transform and nonlinear features. Comput Methods Programs Biomed 2018; 166:91-98. [PMID: 30415722 DOI: 10.1016/j.cmpb.2018.10.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Revised: 08/24/2018] [Accepted: 10/01/2018] [Indexed: 06/09/2023]
Abstract
BACKGROUND AND OBJECTIVE Liver fibrosis is a type of chronic liver injury that is characterized by an excessive deposition of extracellular matrix protein. Early detection of liver fibrosis may prevent further growth toward liver cirrhosis and hepatocellular carcinoma. In the past, the only method to assess liver fibrosis was through biopsy, but this examination is invasive, expensive, prone to sampling errors, and may cause complications such as bleeding. Ultrasound-based elastography is a promising tool to measure tissue elasticity in real time; however, this technology requires an upgrade of the ultrasound system and software. In this study, a novel computer-aided diagnosis tool is proposed to automatically detect and classify the various stages of liver fibrosis based upon conventional B-mode ultrasound images. METHODS The proposed method uses a 2D contourlet transform and a set of texture features that are efficiently extracted from the transformed image. Then, the combination of a kernel discriminant analysis (KDA)-based feature reduction technique and analysis of variance (ANOVA)-based feature ranking technique was used, and the images were then classified into various stages of liver fibrosis. RESULTS Our 2D contourlet transform and texture feature analysis approach achieved a 91.46% accuracy using only four features input to the probabilistic neural network classifier, to classify the five stages of liver fibrosis. It also achieved a 92.16% sensitivity and 88.92% specificity for the same model. The evaluation was done on a database of 762 ultrasound images belonging to five different stages of liver fibrosis. CONCLUSIONS The findings suggest that the proposed method can be useful to automatically detect and classify liver fibrosis, which would greatly assist clinicians in making an accurate diagnosis.
Collapse
Affiliation(s)
- U Rajendra Acharya
- Department of Electronics and Computer Engineering, Ngee Ann Polytechnic, Clementi 599489, Singapore; Department of Biomedical Engineering, School of Science and Technology, Singapore University of Social Sciences, Clementi 599491, Singapore; School of Medicine, Faculty of Health and Medical Sciences, Taylor's University, 47500 Subang Jaya, Malaysia
| | - U Raghavendra
- Department of Instrumentation and Control Engineering, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal 576104, India
| | - Joel E W Koh
- Department of Electronics and Computer Engineering, Ngee Ann Polytechnic, Clementi 599489, Singapore
| | - Kristen M Meiburger
- Department of Electronics and Telecommunications, Politecnico di Torino, Corso Duca degli Abruzzi, 24, 10129 Torino, Italy.
| | - Edward J Ciaccio
- Department of Medicine, Columbia University, New York, NY, 10032, USA
| | - Yuki Hagiwara
- Department of Electronics and Computer Engineering, Ngee Ann Polytechnic, Clementi 599489, Singapore
| | - Filippo Molinari
- Department of Electronics and Telecommunications, Politecnico di Torino, Corso Duca degli Abruzzi, 24, 10129 Torino, Italy
| | - Wai Ling Leong
- Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Anushya Vijayananthan
- Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Nur Adura Yaakup
- Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Mohd Kamil Bin Mohd Fabell
- Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Chai Hong Yeong
- Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia; School of Medicine, Faculty of Health and Medical Sciences, Taylor's University, 47500 Subang Jaya, Malaysia
| |
Collapse
|
8
|
Leong WL, Sharifpoor S, Battiston K, Charleton D, Corrigan M, McCready DR, Done SJ, Santerre JP. Abstract P2-12-15: ReFilx- synthetic biodegradable soft tissue fillers for breast conserving surgery in breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p2-12-15] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Breast conserving surgery (BCS) is the most common procedure performed in breast cancers, but it can often result in breast deformities that can have negative impacts on quality of life. With better treatments, more breast cancer survivors are expected to live longer, the demand for achieving optimal cosmetic outcomes has also increased accordingly. Currently, oncoplastic techniques involving local tissue rearrangement with or without contralateral balancing procedures are used in specialized centers to achieve breast symmetry in some patients. When a breast deformity occurs, corrective options include: fat grafting, autologous flap procedures and completion mastectomy with immediate reconstruction. These techniques have long operative times, longer length of hospital stay and higher complication rates. Commercially-available synthetic implants are fabricated in pre-determined sizes and thus are not suitable to reconstruct partial breast deformities of varying size and shape. We explored the use of amino-acid based biodegradable polyurethanes as tissue fillers for BCS due to their chemical versatility, superior mechanical properties and tailored biocompatibility. Objective: To evaluate novel biodegradable polymer constructs, referred to as ReFilx, as soft tissue fillers for BCS defects. Hypothesis: Implantation of ReFilx during BCS will maintain breast shape and size and promote tissue regeneration in and around the biodegradable biomaterial, in contrast to sham controls. Methods: Two ReFilx formulations with high porosity, mechanical properties (compressive modulus=45±6 kPa and 31±9 kPa) comparable to native breast tissue and a moderate degree of swelling (202±6% and 248±6%) were selected for implantation in porcine BCS defects. Three female Yucatan Minipigs (age=4 years, weight=100-120 kg, 12 breasts per pig) received BCS to remove normal breast tissue of approximately 2 cm diameter, after which the defects were filled with ReFilx Formulation A, ReFilx Formulation B, or no filler (sham control). At 6, 12, 24, and 36 weeks post-implantation (n=3 per group), ultrasound breast examinations and mastectomies of each selected group of breasts were performed. Samples were fixed in 10% buffered formalin and stained with H&E, Masson's Trichrome and immunohistomchemistry using CD31. Results: ReFilx formulations maintained breast size and shape, with similar stiffness to native breast tissue, while sham controls collapsed over 36 weeks. The ReFilx fillers supported cell and tissue infiltration and neovascularization, as indicated by Masson's Trichrome and CD31 staining, respectively, without eliciting foreign body giant cell formation, fibrosis, or chronic inflammation, commonly associated with implanted medical devices. Conclusions: ReFilx are promising soft tissue fillers for breast volume restoration, representing a simple, versatile, permanent, and aesthetically superior solution to prevent soft tissue deformities. Acknowledgements: MaRS PoP fund, grant # MI 2011-170, NSERC # SYN 430828. Haynes Connell Foundation Breast Cancer Fund.
Citation Format: Leong WL, Sharifpoor S, Battiston K, Charleton D, Corrigan M, McCready DR, Done SJ, Santerre JP. ReFilx- synthetic biodegradable soft tissue fillers for breast conserving surgery in breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P2-12-15.
Collapse
Affiliation(s)
- WL Leong
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Translational Biology and Engineering Progra, University of Toronto, Toronto, ON, Canada; Campbell Family Institute of Breast Cancer Research, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Cork Breast Research Centre, Cork, Munster, Ireland; Grand River Hospital, Kitchener, ON, Canada
| | - S Sharifpoor
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Translational Biology and Engineering Progra, University of Toronto, Toronto, ON, Canada; Campbell Family Institute of Breast Cancer Research, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Cork Breast Research Centre, Cork, Munster, Ireland; Grand River Hospital, Kitchener, ON, Canada
| | - K Battiston
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Translational Biology and Engineering Progra, University of Toronto, Toronto, ON, Canada; Campbell Family Institute of Breast Cancer Research, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Cork Breast Research Centre, Cork, Munster, Ireland; Grand River Hospital, Kitchener, ON, Canada
| | - D Charleton
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Translational Biology and Engineering Progra, University of Toronto, Toronto, ON, Canada; Campbell Family Institute of Breast Cancer Research, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Cork Breast Research Centre, Cork, Munster, Ireland; Grand River Hospital, Kitchener, ON, Canada
| | - M Corrigan
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Translational Biology and Engineering Progra, University of Toronto, Toronto, ON, Canada; Campbell Family Institute of Breast Cancer Research, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Cork Breast Research Centre, Cork, Munster, Ireland; Grand River Hospital, Kitchener, ON, Canada
| | - DR McCready
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Translational Biology and Engineering Progra, University of Toronto, Toronto, ON, Canada; Campbell Family Institute of Breast Cancer Research, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Cork Breast Research Centre, Cork, Munster, Ireland; Grand River Hospital, Kitchener, ON, Canada
| | - SJ Done
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Translational Biology and Engineering Progra, University of Toronto, Toronto, ON, Canada; Campbell Family Institute of Breast Cancer Research, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Cork Breast Research Centre, Cork, Munster, Ireland; Grand River Hospital, Kitchener, ON, Canada
| | - JP Santerre
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Translational Biology and Engineering Progra, University of Toronto, Toronto, ON, Canada; Campbell Family Institute of Breast Cancer Research, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Cork Breast Research Centre, Cork, Munster, Ireland; Grand River Hospital, Kitchener, ON, Canada
| |
Collapse
|
9
|
Leong WL. Optimising triggers for patient-assisted remifentanil analgesia during labour - a reply. Anaesthesia 2017; 72:1156. [PMID: 28804884 DOI: 10.1111/anae.14025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- W L Leong
- KK Women's and Children's Hospital, Singapore
| |
Collapse
|
10
|
Leong WL, Sng BL, Zhang Q, Han NLR, Sultana R, Sia ATH. A case series of vital signs-controlled, patient-assisted intravenous analgesia (VPIA) using remifentanil for labour and delivery. Anaesthesia 2017; 72:845-852. [PMID: 28418067 DOI: 10.1111/anae.13878] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/26/2017] [Indexed: 11/27/2022]
Abstract
Intravenous remifentanil patient-controlled analgesia can be used during labour as an alternative to epidural analgesia. Adverse effects of opioids, including hypoxia and bradycardia, may lead to maternal morbidity and mortality. We devised an interactive feedback system based on a clinical proportional algorithm, to continuously monitor for adverse effects to enhance safety and better titrate analgesia. This vital signs-controlled, patient-assisted intravenous analgesia with remifentanil used a prototype delivery system linked to a pulse oximeter that evaluated maternal oxygen saturation and heart rate continuously. With this system, we detected oxygen saturation < 95% for more than 60 s in 15 of 29 subjects (52%); and heart rate < 60 min-1 for more than 60 s in 7 of 29 subjects (24%) during use. The system automatically responded appropriately by reducing the dosages and temporarily halting remifentanil administration, thus averting further hypoxia and bradycardia.
Collapse
Affiliation(s)
- W L Leong
- Department of Women's Anaesthesia, KK Women's and Children's Hospital, Singapore
| | - B L Sng
- Department of Women's Anaesthesia, KK Women's and Children's Hospital, Singapore.,Duke-NUS Medical School, Singapore
| | - Q Zhang
- SingHealth Anaesthesiology Residency Program, Singapore
| | - N L R Han
- Division of Clinical Support Services, KK Women's and Children's Hospital, Singapore
| | - R Sultana
- Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore
| | - A T H Sia
- Department of Women's Anaesthesia, KK Women's and Children's Hospital, Singapore.,Duke-NUS Medical School, Singapore
| |
Collapse
|
11
|
Tien JC, Lim MJ, Leong WL, Lew E. Nine-year audit of post-dural puncture headache in a tertiary obstetric hospital in Singapore. Int J Obstet Anesth 2016; 28:34-38. [PMID: 27641087 DOI: 10.1016/j.ijoa.2016.06.005] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2016] [Revised: 06/04/2016] [Accepted: 06/26/2016] [Indexed: 10/21/2022]
Abstract
BACKGROUND The KK Women's and Children's Hospital is a tertiary obstetric unit with approximately 11000 deliveries per year. Epidural analgesia is used in about 40% of laboring women. We reviewed the incidence and management of post-dural puncture headache over a nine-year period. METHODS A retrospective audit of labor epidural analgesia database records from 1 June 2005 to 31 May 2014 was conducted, identifying an "event" as an accidental dural puncture, an inadvertent intrathecal catheter insertion and/or development of a post-dural puncture headache. RESULTS A total of 43434 epidural records were reviewed. Sixty-three events were identified (an incidence of 0.15%). Women had median age of 30years and median body mass index of 27.6kg/m2; 69.8% (44/63) delivered vaginally. Procedures performed by less experienced anesthesiologists and those performed outside office hours were associated with a higher incidence of accidental dural puncture. An intrathecal catheter was inserted in 52 of 58 women (89.7%). Headache developed in 24 of 38 (63.1%) women in whom there was a witnessed accidental dural puncture. Most women who developed post-dural puncture headache presented during the primary admission (36/39; 92.3%). Paracetamol and non-steroidal anti-inflammatory drugs were the most commonly prescribed medications. Six women (9.5%) received an epidural blood patch which led to resolution of headache. CONCLUSION A retrospective audit over a nine-year period at a tertiary teaching hospital found the overall incidence of post-dural puncture headache and associated events to be 0.15%, with a decreasing trend coinciding with improvement in the teaching and supervision of trainees in labor epidural procedures.
Collapse
Affiliation(s)
- J C Tien
- Department of Women's Anesthesia, KK Women's and Children's Hospital, Singapore.
| | - M J Lim
- Department of Women's Anesthesia, KK Women's and Children's Hospital, Singapore
| | - W L Leong
- Department of Women's Anesthesia, KK Women's and Children's Hospital, Singapore
| | - E Lew
- Department of Women's Anesthesia, KK Women's and Children's Hospital, Singapore
| |
Collapse
|
12
|
Valic MS, Leong WL, Done SJ, Wilson BC, Kulkarni S, McCready DR, Niu CJ, Atachia Y, Munro EA, Rempel D. Abstract P4-03-05: Wide-field optical coherence tomography (WF-OCT) for near real-time, point-of-care assessment of margin status in breast-conserving surgery specimens: Results of a feasibility study at a high-volume single-centre. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p4-03-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Wide-Field Optical Coherence Tomography (WF-OCT) is a non-destructive, non-contact light imaging modality capable of label-free visualization of the internal microscopic architecture of breast tissue specimens. Its unique combination of high-resolution imaging in near real-time with tissue penetration depths approaching 2-mm makes it a promising imaging modality for obtaining detailed surgical margin status in breast-conserving surgery (BCS) specimens. A prototype WF-OCT imaging platform developed by Perimeter Medical Imaging, Inc. (Toronto, Canada) has permitted fully-automated, dynamically-focused visualization of margin widths around the intact surfaces of freshly excised BCS specimens. Herein are reported the results of a feasibility study at a high-volume single-centre evaluating the routine use of WF-OCT for sampling of surgical margin status in BCS specimens at the point-of-care.
Methods: Women with biopsy confirmed breast cancer and scheduled for primary BCS were recruited at Princess Margaret Cancer Centre (Toronto, Canada). Standard medical care was not altered. Freshly excised BCS specimens including all lumpectomy samples were imaged by WF-OCT immediately prior to standard histological processing. The system acquired dynamically-focused, hemispherical coverage over two contra-lateral surfaces of the intact BCS specimen within the time constraints of the cold ischemic time window. High-resolution (10 μm) images of the tissue surface down to a 1 to 2-mm depth were obtained. Blinded assessments were performed on image data sets by two clinical readers (surgeon and radiologist) trained on a validated and unrelated data set correlating OCT images with histology slides. The readers were first asked to independently assess margin status using only blinded pre- and intra-operative knowledge (without OCT). Upon completion, the readers were provided OCT images of all scanned surface and similarly asked to assess the margin status with the additional OCT information. These assessments were subsequently evaluated by a breast pathologist comparing the OCT images and corresponding histopathology sections. The added utility of WF-OCT imaging information for margin prediction was studied.
Results: [Pending study completion in August 2015]. Through accurate correlation with the histopathologic gold standard, OCT demonstrated capability to differentiate tissue microstructures, including: distinctive patterns for adipose tissue, fibrous stroma, breast lobules and ducts, cysts and microcysts, as well as in-situ and invasive carcinomas.
Implications: The fully-automated WF-OCT imaging platform can integrate conveniently into standard pathological processing workflows to provide comprehensive sampling of surgical margin status in BCS specimens at the point-of-care. Clinical readers from surgical and radiological backgrounds can be trained to competently interpret WF-OCT images of BCS specimens for accurate prediction margin status. The implementation of WF-OCT at the point-of-care for routine surgical margin assessments will be further explored in future clinical trials.
Citation Format: Valic MS, Leong WL, Done SJ, Wilson BC, Kulkarni S, McCready DR, Niu CJ, Atachia Y, Munro EA, Rempel D. Wide-field optical coherence tomography (WF-OCT) for near real-time, point-of-care assessment of margin status in breast-conserving surgery specimens: Results of a feasibility study at a high-volume single-centre. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P4-03-05.
Collapse
Affiliation(s)
- MS Valic
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - WL Leong
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - SJ Done
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - BC Wilson
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - S Kulkarni
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - DR McCready
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - CJ Niu
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - Y Atachia
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - EA Munro
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| | - D Rempel
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; The Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Perimeter Medical Imaging, Inc., Toronto, ON, Canada; University Health Network, Toronto, ON, Canada
| |
Collapse
|
13
|
Leong WL, Wang DY, Done S, McCready D. Abstract P2-10-34: Development and validation of ClinicoMolecular Triad Classification (CMTC), a platform for breast cancer (BC) prognostic and predictive gene signature portfolios. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p2-10-34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Numerous gene signatures have claimed prognostic significance in BCs. Each of these gene signatures was designed to answer a specific clinical or biological question, often by dichotomizing the targeted populations into a good and a bad risk group. None of these gene signatures on its own has sufficient degree of complexity to fully characterize this very heterogenous group of diseases, and hence lacks the flexibility to personalize treatments. To exploit the full potential of the genomic approach, we developed an 803-gene molecular classification, termed ClinicoMolecular Triad Classification (CMTC) that categorized BCs into 3 clinical treatment groups (triad) that can serve as a basic framework to guide management. CMTC also provide a detailed “portfolio” of 14 other gene signatures and 19 oncogenic pathways to allow further customization of the treatments. The ability to get CMTC portfolio results at the time of initial diagnosis offers the unique advantage of early treatment planning, including the use of pre-operative chemotherapy to improve breast conservation in selected patients. This study aimed to validate the CMTC classification using an independent BC cohort.
Study design/ results: RNA from fine needle aspirates were collected in a prospective BC cohort (n = 340) between 2008 and 2010 at Princess Margaret Hospital and Mount Sinai Hospital, Toronto, we included all newly diagnosed BC patients going for surgery who consented to join the study. DNA microarray analyses were carried out using genome-wide Illumina Human Ref-8 version 3 Beadarrays, which contained >24K oligonucleotide probes. After excluding tumors with low RNA yield (n = 8, success rate 97%), non-invasive cancers (n = 27), insufficient follow-up data (n = 21), CMTC divided the remaining 284 BCs into 3 similar sized groups (triad). At a median follow-up of 32 months (range 6.3–52 months), the short-term recurrence was significantly worse (p = 0.0048) in the poor prognostic groups. This result was similar to using an independent external validation cohort (n = 2100) with long-term follow-up reported before, CMTC outperformed all other gene signatures in predicting prognosis and treatment response.
Discussion/conclusion: This prospective validation cohort study demonstrated reproducibility of CMTC in classifying BCs into the three major treatment groups and its prognostic significance. CMTC can be used as a platform to personalize treatments: CMTC-1 BCs (ER+, low proliferation) in general can be treated with surgery and tamoxifen alone. CMTC-2 tumours (ER+, high proliferation) will require additional treatments, including chemotherapy, in addition to tamoxifen; other biologics can be prescribed based on the activities of additional oncogenic pathways. Neo-adjuvant chemotherapy should be considered for CMTC-3 tumours (triple negative and HER2+) with addition of trastuzumab in those that show activation of the HER2 pathway. CMTC portfolio is being further developed into a genomic platform to guide personalized BC treatments..
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P2-10-34.
Collapse
Affiliation(s)
- WL Leong
- University Health Network, Toronto, ON, Canada
| | - D-Y Wang
- University Health Network, Toronto, ON, Canada
| | - S Done
- University Health Network, Toronto, ON, Canada
| | - D McCready
- University Health Network, Toronto, ON, Canada
| |
Collapse
|
14
|
Harewood GC, Chrysostomou K, Himy N, Leong WL. A "time-and-motion" study of endoscopic practice: strategies to enhance efficiency. Gastrointest Endosc 2008; 68:1043-50. [PMID: 19028212 DOI: 10.1016/j.gie.2008.03.1116] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/04/2007] [Accepted: 03/25/2008] [Indexed: 02/08/2023]
Abstract
BACKGROUND With the growing demand on endoscopic resources, achieving optimal efficiency has assumed increasing importance. OBJECTIVE This study adopted a time-and-motion approach to assess efficiency in the endoscopy unit of a large teaching hospital and to identify strategies to enhance efficiency. DESIGN Consecutive endoscopic procedures were prospectively observed over the study period, and time intervals of the individual components of each procedure were recorded. SETTING Tertiary-referral teaching hospital. PATIENTS Consecutive patients undergoing endoscopy. INTERVENTION Prospective recording of endoscopic data. MAIN OUTCOME MEASUREMENTS Time intervals of the individual components of each procedure. RESULTS Data were prospectively recorded for 400 procedures: 197 EGDs, 123 colonoscopies, 32 flexible sigmoidoscopies, and 48 double procedures (an EGD and a flexible sigmoidoscopy or colonoscopy). Several strategies to improve the efficiency quotient (EQ), the proportion of time that the endoscopist is engaged in performing the procedure or completing postprocedure paperwork, were identified: (1) employing personnel to obtain prior intravenous access and consent of patients increased the EQ by 10.8%, (2) using a 2-rooms-per-endoscopist model increased the EQ by 51.2%, (3) using personnel to both obtain consent and sedate the patient before an endoscopy increased the EQ by 30.9%, and (4) eliminating postprocedure paperwork for the endoscopist in conjunction with preconsent and sedation and a 2-room model increased the EQ by 63.3%. LIMITATIONS Findings represent the experience of a single endoscopy unit in a tertiary-referral center and may not be generalizable to ambulatory surgical centers or other hospital-based endoscopy units. Factors other than procedure-time components may impact the efficiency of a 2-rooms-per-endoscopist model. CONCLUSIONS A time-and-motion approach can be used to identify strategies to enhance endoscopic efficiency. The quality of any aspect of endoscopy performance should never be compromised in an attempt to enhance efficiency.
Collapse
Affiliation(s)
- Gavin C Harewood
- Department of Gastroenterology and Hepatology, Beaumont Hospital, Dublin, Ireland
| | | | | | | |
Collapse
|
15
|
Harewood GC, Murray F, Patchett S, Garcia L, Leong WL, Lim YT, Prabakaran S, Yeen KF, O'Flynn J, McNally E. Assessment of colorectal cancer knowledge and patient attitudes towards screening: is Ireland ready to embrace colon cancer screening? Ir J Med Sci 2008; 178:7-12. [PMID: 18584273 DOI: 10.1007/s11845-008-0163-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2007] [Accepted: 04/14/2008] [Indexed: 02/08/2023]
Abstract
INTRODUCTION The level of awareness among the Irish public regarding colorectal cancer (CRC) remains uncertain. This study aimed to characterise CRC knowledge levels among a cohort of Irish patients. METHODS A survey evaluating CRC knowledge levels was distributed among outpatients at a gastroenterology clinic in a Dublin teaching hospital. RESULTS In total, 472 surveys were distributed of which 465 (98.5%) were returned. Twenty-nine percent of respondents correctly judged CRC to be the commonest cause of cancer death among the options provided while 26% correctly judged the lifetime risk of CRC; 59% underestimated and 15% overestimated the risk. Most patients (91%) were willing to pay 300 euros for a prompt colonoscopy if recommended by their physician while 7% opted to wait 6 months for a free colonoscopy. CONCLUSIONS There is a willingness to embrace CRC screening and to shoulder some of the financial burden that this entails.
Collapse
Affiliation(s)
- G C Harewood
- Department of Gastroenterology, Beaumont Hospital Dublin, Dublin, Ireland.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Abstract
AIMS Sentinel lymph node biopsy (SLNB) is an important component in the staging and treatment of cutaneous melanoma (CM). The medical literature provides only limited information regarding melanoma sentinel lymph node (SLN) histology. This report details the specific histological patterns of melanoma metastases in sentinel lymph nodes (SLNs) and highlights some key factors in evaluating SLNs for melanoma. METHODS From 281 SLNB cases between June 1998 and May 2002, 79 consecutive cases of SLN biopsies positive for metastases from CM were retrospectively reviewed. The important characteristics of the SLNs and the metastatic foci are described. RESULTS The median size of positive SLNs was 17 mm (range, 5-38). SLNs had a median of two metastatic foci (range, 1-11), with the largest foci being a median of 1.1 mm in size (range, 0.05-24). S-100 and HMB-45 staining was positive in 100% and 92% of the detected metastatic foci, respectively. The metastatic melanoma cells were epithelioid, spindled, and mixed in 86%, 5%, and 9% of cases. Metastatic foci were most often (86%) found in the subcapsular region of the SLN. Benign naevic cells were found coexisting in 14% of positive SLNs. CONCLUSIONS Staining for S100 is more sensitive than HMB-45 (100% v 92%), but HMB-45 staining helped to distinguish benign naevic cells from melanoma. The subcapsular region was crucial in SLN evaluation, because it contained the metastases in 86% of cases. Evaluation of the subcapsular space should not be compromised by cautery artefacts or incomplete excision of the SLN.
Collapse
Affiliation(s)
- C A Murray
- Department of Dermatology, University of Toronto, Toronto, Ontario, Canada
| | | | | | | |
Collapse
|
17
|
Leong WL, Dobson MJ, Logsdon JM, Abdel-Majid RM, Schalkwyk LC, Guernsey DL, Neumann PE. ETn insertion in the mouse Adcy1 gene: transcriptional and phylogenetic analyses. Mamm Genome 2000; 11:97-103. [PMID: 10656922 DOI: 10.1007/s003350010020] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Early retrotransposons (ETn) are murine transposable elements, bearing some structural similarity to integrated proviruses, and can be insertional mutagens. We have recently identified the causative mutation of the barrelless (Adcy1brl) phenotype as an integration of a 5.7-kb ETn in an intron of the adenylyl cyclase type I (Adcy1) gene. In the present study, Northern blot analysis shows that the ETn insertion results in loss of the normal Adcy1 transcript, a finding consistent with the loss-of-function Adcy1brl mutation, and generation of shorter transcripts. These aberrant transcripts are the products of abnormal RNA splicing and termination owing to the inserted sequence, and transcription initiation within the 3' long terminal repeat (LTR) of the ETn. The DNA sequences of the LTRs were compared in phylogenetic analyses with LTRs from 22 other ETn-related sequences. Three distinct families of ETn sequences can be identified on the basis of their LTRs. The ETn found in Adcy1brl is a member of a family that includes all classified ETn elements known to have recently transposed. Further, of the four known solitary (solo) LTRs, we have identified two that show evidence of recombination between LTRs from different ETn families.
Collapse
Affiliation(s)
- W L Leong
- Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
| | | | | | | | | | | | | |
Collapse
|
18
|
Abdel-Majid RM, Leong WL, Schalkwyk LC, Smallman DS, Wong ST, Storm DR, Fine A, Dobson MJ, Guernsey DL, Neumann PE. Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex. Nat Genet 1998; 19:289-91. [PMID: 9662407 DOI: 10.1038/980] [Citation(s) in RCA: 134] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
The somatosensory (SI) cortex of mice displays a patterned, nonuniform distribution of neurons in layer IV called the 'barrelfield' (ref. 1). Thalamocortical afferents (TCAs) that terminate in layer IV are segregated such that each barrel, a readily visible cylindrical array of neurons surrounding a cell-sparse center, represents a distinct receptive field. TCA arbors are confined to the barrel hollow and synapse on barrel-wall neurons whose dendrites are oriented toward the center of the barrel. Mice homozygous for the barrelless (brl) mutation, which occurred spontaneously in ICR stock at Université de Lausanne (Switzerland), fail to develop this patterned distribution of neurons, but still display normal topological organization of the SI cortex. Despite the absence of barrels and the overlapping zones of TCA arborization, the size of individual whisker representations, as judged by 2-deoxyglucose uptake, is similar to that of wild-type mice. We identified adenylyl cyclase type I (Adcy1) as the gene disrupted in brl mutant mice by fine mapping of proximal chromosome 11, enzyme assay, mutation analysis and examination of mice homozygous for a targeted disruption of Adcy1. These results provide the first evidence for involvement of cAMP signalling pathways in pattern formation of the brain.
Collapse
Affiliation(s)
- R M Abdel-Majid
- Department of Anatomy & Neurobiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Skiadopoulos MH, Salvino R, Leong WL, Faust EA. Characterization of linker insertion and point mutations in the NS-1 gene of minute virus of mice: effects on DNA replication and transcriptional activation functions of NS-1. Virology 1992; 188:122-34. [PMID: 1533078 DOI: 10.1016/0042-6822(92)90741-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The NS-1 gene of minute virus of mice encodes a multifunctional protein required for replication of the viral genome and for transcriptional regulation of the two MVM promoters. To study the localization of activities required for DNA replication and transactivation of the capsid gene promoter, insertion and point mutations were introduced into the NS-1 gene. The mutant NS-1 genes were expressed in COS-7 cells by using an SV 40 promoter driven NS-1 expression vector. The ability of the mutant proteins to complement a replication defective NS-1 mutant of the infectious MVM plasmid pMM984 and to activate transcription from the capsid gene promoter in chloramphenicol acetyl transferase expression assays was determined. Two point mutations Ser-249 to Ala and Lys-250 to Gln and a one amino acid insertion between Asp-606 and Leu-607 had no effect on viral DNA replication and transactivation activities. Six independent insertions of between 2 and 12 amino acids inhibited the DNA replication activity of NS-1 between 20- and at least 100-fold. There was no apparent correlation between the extent of inhibition of parvoviral DNA replication and the location of the mutations. The transcriptional activation function of NS-1 was inhibited between 1.5- and at least 20-fold and was therefore overall relatively less sensitive to mutagenesis than was its DNA replication function. An exception to this was a 5 amino acid insertion between Tyr-543 and Gln-544 that abolished transactivation as well as the ability of NS-1 to complement viral DNA replication.
Collapse
Affiliation(s)
- M H Skiadopoulos
- Department of Biochemistry, Dalhousie University, Halifax, Nova Scotia
| | | | | | | |
Collapse
|